Study on the efficacy of sevelamer carbonate versus calcium carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis at Pusat Penyelidikan Klinikal Clinical Research Centre (CRC) Hospital Serdang / Siti Rohaya Daud

Daud, Siti Rohaya (2014) Study on the efficacy of sevelamer carbonate versus calcium carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis at Pusat Penyelidikan Klinikal Clinical Research Centre (CRC) Hospital Serdang / Siti Rohaya Daud. Degree thesis, Universiti Teknologi MARA Cawangan Kelantan.

Download

[thumbnail of 33635.pdf] Text
33635.pdf

Download (24kB)

Abstract

Hyperphosphatemia (HyperPO4) and chronic kidney disease are metabolic bone disease that is common in end stage renal disease. Untreated hyperphosphatemia can lead to cardiovascular disease and calciphylaxis. It is a risk factor for cardiovascular disease and independently associated with mortality. Calcium based phosphate binders can cause progression in vascular calcification, which is a recognised risk factor for cardiovascular disease in chronic kidney disease patients. Sevelamer is a non calcium-based phosphate binder which has been showed to be effective on controlling hyperphosphatemia and reducing serum phosphorus in patients with chronic kidney disease. 310 patients from Hospital Serdang were screened for eligibility. 114 patients were eligible, 62 patients declined to give informed consent and 5 patients withdrawn consent before randomisation. Approximately fifty two (52) patients were enrolled in this prospective open-labelled crossover trial. This study used a randomized, open-label, crossover design study which compares the efficacy of Sevelamer Carbonate versus Calcium Carbonate in the treatment of hypherphosphatemia in patients with chronic kidney disease on dialysis. Based on the findings, it was found that sevelamer carbonate gives equally significant effective in comparing with calcium carbonate as the treatment of hyperphosphatemia in chronic kidney disease. Sevelamer carbonate can be used in the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis

Metadata

Item Type: Thesis (Degree)
Creators:
Creators
Email
Daud, Siti Rohaya
2010615032
Contributors:
Contribution
Name
Email / ID Num.
Thesis advisor
Wan Yaacob, Wan Fairos
UNSPECIFIED
Subjects: R Medicine > RC Internal Medicine > Chronic diseases
Divisions: Universiti Teknologi MARA, Kelantan > Kota Bharu Campus > Faculty of Computer and Mathematical Sciences
Item ID: 33635
Uncontrolled Keywords: Controlling hyperphosphatemia , reducing serum phosphorus,kidney diseases
URI: https://ir.uitm.edu.my/id/eprint/33635

Fulltext

Fulltext is available at:
  • Bilik Koleksi Akses Terhad Kampus Kota Bharu, Kelantan
  • ID Number

    33635

    Indexing


    View in Google Scholar

    Edit Item
    Edit Item